Patient diversity in clinical research populations has become a strategic focus of stakeholders throughout the industry and by regulatory authorities throughout the world. There are many common challenges in the recruitment and retention of diverse populations for participation in clinical trials. But, with the right strategy, an ongoing commitment to ensuring representation and a collaborative effort between the CRO, the sponsor and investigative sites, representative diversity in trial populations can be achieved. The key to achieving representative patient diversity in clinical trials is to understand the importance of selecting the correct mix of diversity strategies to create a nuanced, protocol-specific diversity initiative.
Join the featured speakers, including representatives from Medpace’s patient recruitment and cardiology team as they discuss challenges and considerations surrounding the recruitment and retention of diverse patient populations to ensure appropriate representation in clinical research.
Attendees will learn:
- The importance of achieving diversity, equity and inclusion in clinical trials
- Common challenges associated with recruiting and retaining historically underrepresented populations in clinical trials; as well as strategies to overcome them
- How to identify strategies to increase interest, accessibility and trial participation for patients in underrepresented populations
The Cardiovascular teams at Medpace are highly skilled in the scientific methodology, standard of care, evolving regulatory requirements and operational considerations that are necessary to bring drugs and devices that treat or prevent heart disease to market. Learn more about our cardiovascular capabilities.